Chimeric Therapeutics is trading 40% down at A$0.00, with the cause unclear.
- Recent closes fluctuated between A$0.00 and A$0.01; supplied price context includes no volume or activity-level details.
- A September 29 application to quote securities filing was identified, but no reliable source linked it to the October 1 move.
- Available market context shows no significant same-direction index move to explain the decline.